Pharmaceutical News

RSS

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

A review article focuses on the efficacy of neutralizing antibodies and vaccines against the SARS-CoV-2 variants.

9 Dec 2021

Older people taking anxiety drugs and antidepressants more likely to suffer postoperative delirium

Older people taking a drug used to treat anxiety and insomnia – nitrazepam – as well as those on antidepressants, are twice as likely to suffer postoperative delirium after hip and knee surgery, a new Australian study has found.

9 Dec 2021

CDC study shows risk of Guillain-Barré syndrome elevated after Ad.26.COV2.S COVID vaccination

Researchers compile available data from the interim analysis of the number of cases of GBS and the risks posed by different vaccines.

8 Dec 2021

An assessment of pH-sensitive cationic lipid nanoparticles for drug delivery

A recent review looks at the molecular design of pH-sensitive cationic lipids and their applications for various tissues and cell types.

7 Dec 2021

New approaches needed to address the U.S. opioid epidemic

To address the U.S. opioid epidemic, policies and guidelines have focused primarily on reducing opioid prescribing and restricting supply. Accordingly, opioid prescribing decreased 38% in the past decade.

7 Dec 2021

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

Octapharma USA today announced the U.S. Food & Drug Administration has approved cutaquig [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] for the treatment of pediatric patients age 2 and older with primary humoral immunodeficiency (PI). The FDA previously approved cutaquig for adults with PI.

7 Dec 2021

Antipsychotic drugs associated with increase in risk of breast cancer

Researchers at Washington University School of Medicine in St. Louis have found that many commonly prescribed antipsychotic medications are associated with a significant increase in risk of breast cancer.

6 Dec 2021

Study shows COVID booster shots work

A new study investigates uses seven different COVID-19 vaccines as the third dose to boost immunity in vulnerable patients.

6 Dec 2021

SARS-CoV-2 virus-like particles elicit potent neutralizing antibody response in variant challenge

Researchers develop a virus-like particle for SARS-CoV-2 based on the co-expression of the spike, membrane, and envelope structural proteins.

6 Dec 2021

Statin treatment shown to be cost-effective for lowering cholesterol in young adults

Statin therapy has been shown cost-effective for lowering cholesterol in young adults, according to a study published in the Journal of the American College of Cardiology.

3 Dec 2021

Hospitals refused to give patients ivermectin. Lockdowns and political pressure followed.

One Montana hospital went into lockdown and called police after a woman threatened violence because her relative was denied her request to be treated with ivermectin.

2 Dec 2021

SARS-CoV-2 infection risks increase with time in fully vaccinated adults

A recent study describes the association between time elapsed since the second dose of the Pfizer-BioNTech BNT162b2 vaccine and risk of COVID-19.

1 Dec 2021

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

New research suggests that a fourth dose of the mRNA-1273 vaccine in kidney transplant recipients improves Delta variant serum neutralization.

1 Dec 2021

Diabetes medication could revolutionize treatment for heart failure

A medication originally used for patients with diabetes is the first to help people with heart failure and could revolutionize treatment, according to new research from the University of East Anglia.

1 Dec 2021

Caffeine increases alertness and detection accuracy for moving targets

In the first study of its kind to explore caffeine's effects on dynamic visual skills, researchers concluded that caffeine increases alertness and detection accuracy for moving targets. Caffeine also improved participants' reaction times.

1 Dec 2021

WHO recommends the use of first long-acting option to protect women from HIV

The first long-acting option to protect women from HIV, proven to reduce women's HIV risk, has been recommended for use by the World Health Organization.

1 Dec 2021

An antiviral regimen based on biomimetic polymers for COVID-19

In a new study published on the bioRxiv* preprint server, scientists proposed the aforementioned mechanism of action (MOA) and have validated it using electron photomicrographs of murine cytomegalovirus (MCMV), which were incubated with a nanoviricide.

30 Nov 2021

Longer between-dose intervals for COVID-19 vaccines may significantly reduce mortality

A recent study, currently available on the medRxiv* preprint server, has shown how longer dosing intervals of vaccines against coronavirus disease (COVID-19) may be able to minimize mortality in low- and middle-income countries in the WHO European region – and significantly change our vaccination strategy.

30 Nov 2021

Imaging drug that illuminates ovarian cancer tissue when exposed to fluorescent light gets FDA approval

The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove the cancer.

30 Nov 2021

Novel influenza vaccine candidate shows promise

Researchers investigate the potential value of a new vaccine candidate for the influenza virus.

29 Nov 2021

Pharmaceutical News

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

Older people taking anxiety drugs and antidepressants more likely to suffer postoperative delirium

CDC study shows risk of Guillain-Barré syndrome elevated after Ad.26.COV2.S COVID vaccination

An assessment of pH-sensitive cationic lipid nanoparticles for drug delivery

New approaches needed to address the U.S. opioid epidemic

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

Antipsychotic drugs associated with increase in risk of breast cancer

Study shows COVID booster shots work

SARS-CoV-2 virus-like particles elicit potent neutralizing antibody response in variant challenge

Statin treatment shown to be cost-effective for lowering cholesterol in young adults

Hospitals refused to give patients ivermectin. Lockdowns and political pressure followed.

SARS-CoV-2 infection risks increase with time in fully vaccinated adults

Fourth shot of Moderna COVID vaccine improves Delta variant neutralization in kidney transplant patients

Diabetes medication could revolutionize treatment for heart failure

Caffeine increases alertness and detection accuracy for moving targets

WHO recommends the use of first long-acting option to protect women from HIV

An antiviral regimen based on biomimetic polymers for COVID-19

Longer between-dose intervals for COVID-19 vaccines may significantly reduce mortality

Imaging drug that illuminates ovarian cancer tissue when exposed to fluorescent light gets FDA approval

Novel influenza vaccine candidate shows promise

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News